T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer

scientific article published on November 2000

T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1521-2254(200011/12)2:6<416::AID-JGM142>3.0.CO;2-Y
P698PubMed publication ID11199262

P2093author name stringKlatzmann D
Cosset FL
Marodon G
Pioche-Durieu C
Zhao-Emonet JC
P2860cites workSCL binds the human homologue of DRG in vivoQ22008035
At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cellsQ29618360
High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytesQ34003623
Transcriptional interference in avian retroviruses—implications for the promoter insertion model of leukaemogenesisQ34257238
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cellsQ35604467
Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteinsQ36487614
Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 geneQ36747167
Negative control region at the 5' end of murine leukemia virus long terminal repeatsQ36766559
Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancerQ36836984
Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor.Q37149903
Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genesQ37401979
Retroviruses as vectorsQ40537182
Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoterQ41266120
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibersQ41342219
Site-directed mutagenesis of virtually any plasmid by eliminating a unique siteQ42611278
Transcriptional interference and termination between duplicated alpha-globin gene constructs suggests a novel mechanism for gene regulationQ43993308
Evaluation of Lymphoid-Specific Enhancer Addition or Substitution in a Basic Retrovirus VectorQ44045500
Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelopeQ45767602
Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivoQ45865684
Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patientsQ45866834
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.Q45866838
Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK geneQ58659768
P433issue6
P304page(s)416-425
P577publication date2000-11-01
P1433published inJournal of Gene MedicineQ15746377
P1476titleT cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer
P478volume2

Reverse relations

cites work (P2860)
Q34120983Absence of functional and structural abnormalities associated with expression of EGFP in the retina
Q25255153Coordinate enhancement of transgene transcription and translation in a lentiviral vector
Q34715929Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors
Q37801839Physiological and tissue-specific vectors for treatment of inherited diseases
Q36716418Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.
Q42807227Replicative retroviral vectors for cancer gene therapy
Q36457016Retrovirus vectors: toward the plentivirus?